Sunshine Heart Announces Exchange and $3.8 Million Offering
31 oct. 2016 09h00 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) (“Sunshine Heart” or the “Company”) today announced that it has entered into a definitive agreement with a...
FDA allows Phrixus’s IND for Carmeseal-MD™ (P-188 NF) in Duchenne muscular dystrophy (DMD)
07 sept. 2016 08h00 HE
|
Phrixus Pharmaceuticals, Inc.
ANN ARBOR, Mich., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Phrixus Pharmaceuticals is announcing that FDA allowed Phrixus’s IND for Carmeseal-MD (P-188 NF) in Duchenne muscular dystrophy (DMD). The...
Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance
16 août 2016 05h30 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today the appointment of Megan Brandt to the position of Vice President of Regulatory Affairs...
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
08 août 2016 05h30 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc....
Sunshine Heart to Announce Second Quarter 2016 Results on August 9, 2016
29 juil. 2016 13h30 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., July 29, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its second quarter 2016 results will be released on Tuesday, August 9, 2016, before...
Sunshine Heart Announces Clinical Update and Product Development Strategy
11 juil. 2016 05h30 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., July 11, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients...
Sunshine Heart Announces OPTIONS HF Clinical Experience
24 mai 2016 05h30 HE
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., May 24, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its C-Pulse® Heart Assist System was featured in a clinical presentation at the Heart...
HeartMate 3 CE Mark Trial 1-Year Results Presented at ISHLT 36th Annual Meeting and Scientific Sessions in Washington, D.C.
28 avr. 2016 11h13 HE
|
International Society for Heart and Lung Transplantation
WASHINGTON, April 28, 2016 (GLOBE NEWSWIRE) -- At today's opening plenary session at the 36th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions,...
Mesoblast Announces Pricing Of Public Offering On Nasdaq
13 nov. 2015 08h38 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO) (ASX:MSB), a world leader in the development of innovative cell-based medicines, today announced...
Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure
29 sept. 2015 21h10 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC:MBLTY) today announced that additional Phase 2 trial results of its lead product candidate for...